Los Angeles Capital Management LLC Protagonist Therapeutics, Inc Transaction History
Los Angeles Capital Management LLC
- $24.7 Billion
- Q3 2024
A detailed history of Los Angeles Capital Management LLC transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 22,446 shares of PTGX stock, worth $934,875. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,446
Previous 30,827
27.19%
Holding current value
$934,875
Previous $1.07 Million
5.62%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding PTGX
# of Institutions
247Shares Held
56.4MCall Options Held
76.3KPut Options Held
114K-
Farallon Capital Management LLC San Francisco, CA5.86MShares$244 Million1.32% of portfolio
-
Black Rock Inc. New York, NY5.76MShares$240 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.43MShares$226 Million3.89% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.22MShares$176 Million0.0% of portfolio
-
State Street Corp Boston, MA3.18MShares$133 Million0.01% of portfolio
About Protagonist Therapeutics, Inc
- Ticker PTGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,084,100
- Market Cap $2.04B
- Description
- Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...